Which patients will benefit most from Secca therapy? With the help of our experienced physician partners, we developed some basic guidelines that can assist in identification of these patients.

The ideal Secca patient is one who has failed conservative therapies such as biofeedback or diet modification, has mild to moderate incontinence as defined as between a 9 and 17 on the Wexner scale, has relatively normal appearing anorectal anatomy without significant scar, tissue loss, or greater than a 30% external anal sphincter disruption as seen on ultrasound or in clinical exam.

That said, Secca has been used to treat severely incontinent patients with great success – and has also shown to be an effective therapy when compared to biofeedback. Many doctors use Secca in these cases because this treatment burns no bridges, and offers a lower cost and low complication alternative to next line treatments, implants or surgery.